Stock Report

All about this stock under one free report Last Updated: 24-Sep-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Auro Laboratories Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

BSE: 530233

₹245.90

up-down-arrow ₹-4.80 (-1.91%)

As on 24-Sep-2026IST

Market cap

info icon

₹153 Cr

Revenue (TTM)

info icon

₹37 Cr

P/E Ratio

info icon

32.7

P/B Ratio

info icon

3.2

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -10.82 216.08 125.54 -10.80 -6.87
EBIT -1.36 1,095.83 950.55 35.30 0.42
Net Profit -2.06 1,095.24 582.58 15.93 -7.01
EPS 7.64 1,095.13 568.91 15.14 -7.38
Book Value -- -- 7.87 10.66 10.15
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-26Mar-25
EBIT-Margin info 17.3013.0526.0723.4110.63
Net Margin info 11.368.8212.0810.799.17
Return on equity info 10.909.9210.637.914.33
Return on Capital info 11.1111.09--9.173.79
Return on Assets info 5.405.294.253.211.99
Debt to Equity (x) info ----0.001.371.05

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Auro Laboratories
--
9.17
3.79
20.37
9.92
Peer Median
--
14.03
16.46
15.49
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

10.63

Higher than Peers by 0.69

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Auro Laboratories
10.63
7.91
4.33
20.46
7.43
Peer Median
9.94
13.45
13.87
14.72
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

4.25

Lower than Peers by 3.29

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Auro Laboratories
4.25
3.21
1.99
11.00
4.40
Peer Median
7.54
7.94
8.04
7.19
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

26.07

Higher than Peers by 16.73

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Auro Laboratories
26.07
23.41
10.63
17.86
6.27
Peer Median
9.34
21.31
10.05
10.28
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

12.08

Higher than Peers by 2.73

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Auro Laboratories
12.08
10.79
9.17
14.13
4.54
Peer Median
9.35
11.88
9.11
6.78
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Auro Laboratories
--
20.63
15.35
16.56
6.65
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

125.54

Higher than Peers by 119.15

Year on year growth in net sales

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Auro Laboratories
125.54
60.74
-64.34
1.40
3.99
Peer Median
6.38
15.92
7.17
10.56
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

950.55

Higher than Peers by 951.58

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Auro Laboratories
950.55
254.01
-78.78
188.60
-8.02
Peer Median
-1.03
24.76
12.05
6.17
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

582.58

Higher than Peers by 573.53

Year on year growth in profit after tax

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Auro Laboratories
582.58
92.14
-76.40
219.09
-14.15
Peer Median
9.04
24.25
22.15
27.97
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

568.91

Higher than Peers by 566.85

Year on year growth in earnings per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Auro Laboratories
568.91
92.14
-76.40
219.09
-14.15
Peer Median
2.05
26.11
8.80
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Auro Laboratories
--
7.87
2.41
22.68
8.50
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Auro Laboratories
--
1.37
1.05
0.63
0.19
Peer Median
0.02
0.17
0.03
0.05
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Auro Laboratories
--
0.39
0.24
0.19
0.12
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

1.08

Lower than Peers by 1.45

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Auro Laboratories
1.08
1.08
0.96
1.29
1.97
Peer Median
2.53
2.23
2.20
1.93
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

0.60

Lower than Peers by 1.17

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Auro Laboratories
0.60
0.60
0.79
0.94
1.32
Peer Median
1.78
1.82
1.72
1.59
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

2.13

Lower than Peers by 8.09

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Auro Laboratories
2.13
2.13
2.74
15.06
5.23
Peer Median
10.23
11.31
12.28
12.45
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

24.85

Lower than Peers by 1.73

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Auro Laboratories
24.85
29.77
49.12
24.97
23.45
Peer Median
26.57
30.82
26.23
23.97
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.33

Lower than Peers by 0.34

Sales / Average Total Assets

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Auro Laboratories
0.33
0.28
0.21
0.76
0.95
Peer Median
0.67
0.72
0.74
0.88
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Auro Laboratories
--
110.10
217.45
87.78
89.77
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Auro Laboratories
--
102.16
113.63
68.04
55.24
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Auro Laboratories
--
327.89
246.16
121.53
83.56
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Auro Laboratories
--
-115.63
84.92
34.28
61.45
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

32.73

Lower than Peers by 26.50

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Auro Laboratories
32.73
46.75
78.15
12.89
13.95
Peer Median
59.23
58.61
39.17
40.74
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

3.23

Lower than Peers by 1.71

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Auro Laboratories
3.23
3.56
3.34
2.39
1.00
Peer Median
4.95
5.02
3.61
3.87
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Auro Laboratories
--
--
--
--
--
Peer Median
0.13
0.11
0.19
0.20
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

14.35

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Auro Laboratories
14.35
18.88
46.33
10.27
7.13
Peer Median
--
47.44
28.79
25.41
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

153

Lower than Peers by 6,456

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Auro Laboratories
153
165
144
100
34
Peer Median
6,609
6,494
3,944
2,959
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...